The dilemma of denosumab: Salvage of a femoral head giant cell tumour

INTRODUCTION: Denosumab is a monoclonal RANKL antibody which has been shown to be highly effective in treating giant cell tumour (GCT) of bone. We report on its use as a neo-adjuvant agent to avoid morbid surgery for an adolescent. PRESENTATION OF CASE: We report a case of a15-year old female with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaston, Czar Louie, Puls, Florian, Grimer, Robert John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245664/
https://www.ncbi.nlm.nih.gov/pubmed/25290381
http://dx.doi.org/10.1016/j.ijscr.2014.09.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245664/
https://www.ncbi.nlm.nih.gov/pubmed/25290381
http://dx.doi.org/10.1016/j.ijscr.2014.09.018

Ejemplares similares